Cargando…

First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021

Detalles Bibliográficos
Autores principales:	Gee, Julianne, Marquez, Paige, Su, John, Calvert, Geoffrey M., Liu, Ruiling, Myers, Tanya, Nair, Narayan, Martin, Stacey, Clark, Thomas, Markowitz, Lauri, Lindsey, Nicole, Zhang, Bicheng, Licata, Charles, Jazwa, Amelia, Sotir, Mark, Shimabukuro, Tom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2021
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344985/ https://www.ncbi.nlm.nih.gov/pubmed/33630816 http://dx.doi.org/10.15585/mmwr.mm7008e3

Ejemplares similares

Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021
por: Shay, David K., et al.
Publicado: (2021)

COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system
por: Chapin-Bardales, Johanna, et al.
Publicado: (2021)

COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023
por: Hause, Anne M., et al.
Publicado: (2023)

Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination — Five U.S. Mass Vaccination Sites, April 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Menstrual irregularities and vaginal bleeding after COVID-19 vaccination reported to v-safe active surveillance, USA in December, 2020–January, 2022: an observational cohort study
por: Wong, Karen K, et al.
Publicado: (2022)

Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe
por: Rosenblum, Hannah G, et al.
Publicado: (2022)

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Reviewers' January—December 2021
Publicado: (2022)

Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United States, August 31–October 23, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
por: Shimabukuro, Tom T., et al.
Publicado: (2021)

January 2022-December 2022
Publicado: (2022)

Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States
por: Abara, Winston E., et al.
Publicado: (2023)

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response
por: Myers, Tanya R., et al.
Publicado: (2023)

Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years — United States, May 17–July 31, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2021–December 2022
por: Bigouette, John Paul, et al.
Publicado: (2023)

PS Division Reports: January - December 1991
por: Azzoni, G
Publicado: (1992)

PS Division Reports: January - December 1990
por: Azzoni, G
Publicado: (1991)

PS division reports january-december, 1998
por: Neboux, Susan
Publicado: (1999)

PS division reports: January-December, 1988
por: Neboux, Susan
Publicado: (1989)

PS Division Reports: January-December, 1989
por: Neboux, Susan
Publicado: (1990)

PS division reports: January-December,1991
por: Neboux, Susan
Publicado: (1992)

PS division reports: January-December, 1987
por: Neboux, Susan, et al.
Publicado: (1988)

PS Division reports: January - December 1994
por: Boimond, D
Publicado: (1995)

PS Division reports: January - December 1993
por: Chanel, M
Publicado: (1994)

PS division reports: January - December 1995
por: Neboux, S
Publicado: (1996)

PS Division Reports: January - December 1996
por: Neboux, S L
Publicado: (1997)

PS Division Reports: January - December 1997
por: Neboux, S L
Publicado: (1998)

PS Division Reports: January - December 1998
por: Neboux, S L
Publicado: (1999)

PS Division Reports: January - December 1999
por: Neboux, S L
Publicado: (2000)

PS Division Reports: January - December 1992
por: CERN. Geneva. Proton Synchrotron Division
Publicado: (1993)

PS Division Reports: January - December 1989
por: CERN. Geneva. Proton Synchrotron Division
Publicado: (1990)

PS Division Reports: January - December 1988
por: CERN. Geneva. Proton Synchrotron Division
Publicado: (1989)

PS Division Reports: January - December 1987
por: CERN. Geneva. Proton Synchrotron Division
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_a51ecv3v76lrptpjh9q7shfoq6